Addition of Blinatumomab to Consolidation Therapy among Older Newly Diagnosed Patients (pts) with BCR::ABL1 Negative B-Lineage Acute Lymphoblastic Leukemia (ALL) in the ECOG-ACRIN E1910 Randomized Phase III Trial Nikolai A. Podoltsev , Zhuoxin Sun , Mark R. Litzow , Elisabeth Paietta , Kathryn G. Roberts , Yanming Zhang , Janis Racevskis , Hillard M. Lazarus , Jacob M. Rowe , Daniel A. Arber , Matthew J. Wieduwilt , Michaela Liedtke , Julie Bergeron , Brent L. Wood , Yaqi Zhao , Gang Wu , Ti-Cheng Chang , Wenchao Zhang , Keith W. Pratz , Shira N. Dinner , Noelle Frey , Steven D. Gore , Bhavana Bhatnagar , Ehab L. Atallah , Geoffrey L. Uy , Deepa Jeyakumar , Tara L. Lin , Cheryl L. Willman , Daniel J. DeAngelo , Shejal B. Patel , Michelle A Elliott , Anjali S. Advani , Dimitrios Tzachanis , Pankit Vachhani , Rupali Roy , Elad Sharon , Richard Little , Harry Erba , Richard M. Stone , Charles G. Mullighan , Martin S. Tallman , Selina Luger , Ryan J Mattison Blood（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
